Lamb Weston is naming a new CEO as the company moved to a loss in its second quarter and trimmed its fiscal 2025 forecast amid weakening demand for frozen potato products in North America. Lamb Weston said that Michael Smith, who currently serves as its chief operating officer, will become its CEO and join its board on Jan. 3, 2025. “Mike’s appointment represents the culmination of a thoughtful, years-long succession planning process by our board, and we are confident he is the right leader to guide Lamb Weston forward,” Chairman W.G. Jurgensen said in a statement.

Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.

This technology reduces carbon emissions by 95% by eliminating the need for on-site personnel.

Shares of Accenture surged Thursday after the professional services and consulting firm reported first-quarter results that topped analysts' estimates and lifted its full-year revenue growth forecast.

Generative AI bookings hit $1.2 billion as Accenture crushes Wall Street forecasts with 9% revenue growth.

American-based construction company Lennar (LEN) missed its fiscal fourth quarter earnings expectations amid higher interest rates that are scaring homebuyers. Lennar Co-CEO Stuart Miller cites the housing market has "proved to be far more challenging as mortgage rates rose almost 100 basis points through the quarter." Now, the company — in addition to the broad homebuilding industry — faces a widespread issue with housing demand lessening compounded by affordability concerns. In the video above, Morning Brief hosts Seana Smith and Brad Smith give more insights into Lennar's fourth quarter performance. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Josh Lynch.

Wall Street Rebounds After Hawkish Fed Sparks Selloff

Sound Shore Management, an investment management firm, has released its investor letter for the third quarter of 2024. A copy of the letter can be downloaded here. The fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) appreciated 6.70% and 6.74%, respectively, in the third quarter of 2024, outperforming 5.89% return for the Standard & Poor’s 500 […]

Olive Garden's owner stuns Wall Street with strong earnings, upbeat guidance, and sizzling same-store sales growth

Nike stepped in something, and it stinks. After decades of stellar sales and stock performance, the company has slipped into decline, and shares, which peaked above $175 just over three years ago, have collapsed to $77. “ Nike second derivative deterioration is a negative,” writes UBS analyst Jay Sole.